These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9480459)

  • 61. What a clinician needs to know about the mechanisms of action of antiarrhythmic drugs.
    Janse MJ
    Clin Cardiol; 1991 Jan; 14(1):65-7. PubMed ID: 2019031
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Diagnostic criteria for arrhythmia].
    Jpn Circ J; 1991; 55 Suppl 2():267-88. PubMed ID: 1920770
    [No Abstract]   [Full Text] [Related]  

  • 63. Combination antiarrhythmic therapy: 1 + 1 > 2?
    Tang L
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1098-100. PubMed ID: 18554208
    [No Abstract]   [Full Text] [Related]  

  • 64. Dyselectrolytemias and arrhythmias.
    Schiraldi F; Di Conza P; Guiotto G; Scott SW
    J Nephrol; 2010; 23 Suppl 16():S182-90. PubMed ID: 21170878
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Antiarrhythmic agents and atrioventricular conduction].
    Knippel M; Rovelli F
    G Ital Cardiol; 1972; 2(1):184. PubMed ID: 5012012
    [No Abstract]   [Full Text] [Related]  

  • 66. [Evaluation of antiarrhythmic drugs by dynamic electrocardiography. Value and limitations].
    Coumel P; Leclercq JF; Maisonblanche P; Escoubet B; Attuel P
    Therapie; 1986; 41(2):95-102. PubMed ID: 3726796
    [No Abstract]   [Full Text] [Related]  

  • 67. [Arrhythmogenic function of antiarrhythmic drugs].
    Halawa B
    Pol Tyg Lek; 1992 Dec 21-28; 47(51-52):1137-40. PubMed ID: 1307103
    [No Abstract]   [Full Text] [Related]  

  • 68. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.
    Surawicz B; Childers R; Deal BJ; Gettes LS; Bailey JJ; Gorgels A; Hancock EW; Josephson M; Kligfield P; Kors JA; Macfarlane P; Mason JW; Mirvis DM; Okin P; Pahlm O; Rautaharju PM; van Herpen G; Wagner GS; Wellens H; ; ;
    J Am Coll Cardiol; 2009 Mar; 53(11):976-81. PubMed ID: 19281930
    [No Abstract]   [Full Text] [Related]  

  • 69. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology.
    Surawicz B; Childers R; Deal BJ; Gettes LS; Bailey JJ; Gorgels A; Hancock EW; Josephson M; Kligfield P; Kors JA; Macfarlane P; Mason JW; Mirvis DM; Okin P; Pahlm O; Rautaharju PM; van Herpen G; Wagner GS; Wellens H; ; ;
    Circulation; 2009 Mar; 119(10):e235-40. PubMed ID: 19228822
    [No Abstract]   [Full Text] [Related]  

  • 70. [Cardiac arrhythmias in the elderly].
    Guize L; Piot O; Lavergne T; Le Heuzey JY
    Bull Acad Natl Med; 2006; 190(4-5):827-41; discussion 873-6. PubMed ID: 17195610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A class III antiarrhythmic agent.
    Pelter MM; Adams MG
    Am J Crit Care; 2002 Jul; 11(4):395-6. PubMed ID: 12102441
    [No Abstract]   [Full Text] [Related]  

  • 72. Antiarrhythmic agents: current status and perspectives.
    Mátyus P; Varró A; Papp JG; Wamhoff H; Varga I; Virág L
    Med Res Rev; 1997 Sep; 17(5):427-51. PubMed ID: 9276860
    [No Abstract]   [Full Text] [Related]  

  • 73. [Drug information: agents for the treatment of cardiac arrhythmias. 5. (2) Arrhythmias relieved by changed impulse conduction/changed cellular reaction pattern].
    Lumholtz IB
    Sygeplejersken; 1980 Jul; 80(30):15. PubMed ID: 6905368
    [No Abstract]   [Full Text] [Related]  

  • 74. [ST-segment depressions-- are you familiar with them?].
    von Bodman G; Brömsen J; Luciani E; Füller M; Block M
    MMW Fortschr Med; 2013 Sep; 155(16):43, 64. PubMed ID: 24279154
    [No Abstract]   [Full Text] [Related]  

  • 75. [The principles of pharmacotherapy for arrhythmia at the turn of the millenium].
    Fazekas T; Liszkai G
    Orv Hetil; 1999 Dec; 140(51):2851-9. PubMed ID: 10647274
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Experimental models of reentry, antiarrhythmic, and proarrhythmic actions of drugs. Complexities galore!
    el-Sherif N
    Circulation; 1991 Oct; 84(4):1871-5. PubMed ID: 1914122
    [No Abstract]   [Full Text] [Related]  

  • 77. [Possibilities of clinical pharmacology in the evaluation of anti-arrhythmia and anti-angina drugs].
    Mazur NA; Metelitsa VI
    Farmakol Toksikol; 1982; 45(3):59-63. PubMed ID: 7095129
    [No Abstract]   [Full Text] [Related]  

  • 78. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The electrophysiologic effects of antiarrhythmic drugs. 1.
    Gettes LS
    RN; 1973 Mar; 36(3):ICU1-7. PubMed ID: 4486742
    [No Abstract]   [Full Text] [Related]  

  • 80. [Letter: Cardiac automatism].
    Porciello PI; Domenichelli B
    G Ital Cardiol; 1973; 3(3):452-6. PubMed ID: 4766980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.